497 related articles for article (PubMed ID: 35929637)
21. Illustrative review of cardiac amyloidosis by multimodality imaging.
Tanaka H
Heart Fail Rev; 2023 Jan; 28(1):113-122. PubMed ID: 35474404
[TBL] [Abstract][Full Text] [Related]
22. Amyloid myopathy: expanding the clinical spectrum of transthyretin amyloidosis-case report and literature review.
Ungericht M; Wanschitz J; Kroiss AS; Röcken C; Schuetz T; Messner M; Zaruba MM; Loescher WN; Poelzl G
J Nucl Cardiol; 2023 Aug; 30(4):1420-1426. PubMed ID: 35581484
[TBL] [Abstract][Full Text] [Related]
23. Frequency of hereditary transthyretin amyloidosis among elderly patients with transthyretin cardiomyopathy.
Maestro-Benedicto A; Vela P; de Frutos F; Mora N; Pomares A; Gonzalez-Vioque E; Briceño A; Cabrera E; Cobo-Marcos M; Dominguez F; Gonzalez-Lopez E; Segovia J; Lara-Pezzi E; Garcia-Pavia P
Eur J Heart Fail; 2022 Dec; 24(12):2367-2373. PubMed ID: 35999650
[TBL] [Abstract][Full Text] [Related]
24. Prospective evaluation of the morbidity and mortality of wild-type and V122I mutant transthyretin amyloid cardiomyopathy: the Transthyretin Amyloidosis Cardiac Study (TRACS).
Ruberg FL; Maurer MS; Judge DP; Zeldenrust S; Skinner M; Kim AY; Falk RH; Cheung KN; Patel AR; Pano A; Packman J; Grogan DR
Am Heart J; 2012 Aug; 164(2):222-228.e1. PubMed ID: 22877808
[TBL] [Abstract][Full Text] [Related]
25. Transthyretin amyloid cardiomyopathy.
Garcia-Pavia P; Domínguez F; Gonzalez-Lopez E
Med Clin (Barc); 2021 Feb; 156(3):126-134. PubMed ID: 33138983
[TBL] [Abstract][Full Text] [Related]
26. Diagnosis and therapeutic approaches to transthyretin amyloidosis.
Ando Y; Ueda M
Curr Med Chem; 2012; 19(15):2312-23. PubMed ID: 22471980
[TBL] [Abstract][Full Text] [Related]
27. Cardiac transthyretin amyloidosis.
Dungu JN; Anderson LJ; Whelan CJ; Hawkins PN
Heart; 2012 Nov; 98(21):1546-54. PubMed ID: 22888163
[TBL] [Abstract][Full Text] [Related]
28.
Tahara N; Lairez O; Endo J; Okada A; Ueda M; Ishii T; Kitano Y; Lee HE; Russo E; Kubo T
ESC Heart Fail; 2022 Feb; 9(1):251-262. PubMed ID: 34841715
[TBL] [Abstract][Full Text] [Related]
29. Spectrum of transthyretin gene mutations and clinical characteristics of Polish patients with cardiac transthyretin amyloidosis.
Gawor M; Holcman K; Franaszczyk M; Lipowska M; Michałek P; Teresińska A; Bilińska ZT; Rubiś P; Kostkiewicz M; Szot W; Podolec P; Grzybowski J
Cardiol J; 2022; 29(6):985-993. PubMed ID: 32789836
[TBL] [Abstract][Full Text] [Related]
30. Temporal Trends of Wild-Type Transthyretin Amyloid Cardiomyopathy in the Transthyretin Amyloidosis Outcomes Survey.
Nativi-Nicolau J; Siu A; Dispenzieri A; Maurer MS; Rapezzi C; Kristen AV; Garcia-Pavia P; LoRusso S; Waddington-Cruz M; Lairez O; Witteles R; Chapman D; Amass L; Grogan M;
JACC CardioOncol; 2021 Oct; 3(4):537-546. PubMed ID: 34729526
[TBL] [Abstract][Full Text] [Related]
31. Prevalence of cardiac amyloidosis among elderly patients with systolic heart failure or conduction disorders.
López-Sainz Á; de Haro-Del Moral FJ; Dominguez F; Restrepo-Cordoba A; Amor-Salamanca A; Hernandez-Hernandez A; Ruiz-Guerrero L; Krsnik I; Cobo-Marcos M; Castro V; Toquero-Ramos J; Lara-Pezzi E; Fernandez-Lozano I; Alonso-Pulpon L; González-López E; Garcia-Pavia P
Amyloid; 2019 Sep; 26(3):156-163. PubMed ID: 31210553
[No Abstract] [Full Text] [Related]
32. Multidisciplinary Approaches for Transthyretin Amyloidosis.
Koike H; Okumura T; Murohara T; Katsuno M
Cardiol Ther; 2021 Dec; 10(2):289-311. PubMed ID: 34089151
[TBL] [Abstract][Full Text] [Related]
33. Design and Rationale the SCAN-MP (Screening for Cardiac Amyloidosis With Nuclear Imaging in Minority Populations) Study.
Ruberg FL; Blaner WS; Chiuzan C; Connors LH; Einstein AJ; Fine D; Helmke S; Kurian D; Pandey S; Raiszadeh F; Rodriguez C; Sabogal N; Teruya S; Winburn M; Chung WK; Cohn E; Miller EJ; Kelly JW; Maurer MS
J Am Heart Assoc; 2023 Apr; 12(8):e028534. PubMed ID: 37066788
[TBL] [Abstract][Full Text] [Related]
34. Transthyretin cardiac amyloidosis: an update on diagnosis and treatment.
Yamamoto H; Yokochi T
ESC Heart Fail; 2019 Dec; 6(6):1128-1139. PubMed ID: 31553132
[TBL] [Abstract][Full Text] [Related]
35. Diflunisal tolerability in transthyretin cardiac amyloidosis: a single center's experience.
Ikram A; Donnelly JP; Sperry BW; Samaras C; Valent J; Hanna M
Amyloid; 2018 Sep; 25(3):197-202. PubMed ID: 30388377
[TBL] [Abstract][Full Text] [Related]
36. Epidemiology and clinical manifestations of cardiac amyloidosis.
Bajwa F; O'Connor R; Ananthasubramaniam K
Heart Fail Rev; 2022 Sep; 27(5):1471-1484. PubMed ID: 34694575
[TBL] [Abstract][Full Text] [Related]
37. Practical recommendations for the diagnosis and management of transthyretin cardiac amyloidosis.
Bistola V; Parissis J; Foukarakis E; Valsamaki PN; Anastasakis A; Koutsis G; Efthimiadis G; Kastritis E
Heart Fail Rev; 2021 Jul; 26(4):861-879. PubMed ID: 33452596
[TBL] [Abstract][Full Text] [Related]
38. Left ventricular structure and function in transthyretin-related versus light-chain cardiac amyloidosis.
Quarta CC; Solomon SD; Uraizee I; Kruger J; Longhi S; Ferlito M; Gagliardi C; Milandri A; Rapezzi C; Falk RH
Circulation; 2014 May; 129(18):1840-9. PubMed ID: 24563469
[TBL] [Abstract][Full Text] [Related]
39. The Role of Scintigraphy with Bone Radiotracers in Cardiac Amyloidosis.
Morfino P; Aimo A; Giorgetti A; Genovesi D; Merlo M; Limongelli G; Castiglione V; Vergaro G; Emdin M
Heart Fail Clin; 2024 Jul; 20(3):307-316. PubMed ID: 38844301
[TBL] [Abstract][Full Text] [Related]
40. Cardiovascular Involvement in Transthyretin Cardiac Amyloidosis.
Lioncino M; Monda E; Palmiero G; Caiazza M; Vetrano E; Rubino M; Esposito A; Salerno G; Dongiglio F; D'Onofrio B; Verrillo F; Cerciello G; Manganelli F; Pacileo G; Bossone E; Golino P; Calabrò P; Limongelli G
Heart Fail Clin; 2022 Jan; 18(1):73-87. PubMed ID: 34776085
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
